{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Foster City",
      "state": "CA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "67557",
      "recalling_firm": "Gilead Sciences, Inc.",
      "address_1": "333 Lakeside Dr",
      "address_2": "",
      "postal_code": "94404-1147",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide including Puerto Rico.",
      "recall_number": "D-1090-2014",
      "product_description": "Atripla (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) Tablets, 30 Tablet Bottles, Rx only.  Manufactured for: Bristol-Myers Squibb & Gilead Sciences, LLC, Foster City, CA 94404.  Made in Ireland. NDC 15584-0101-1.    Manufactured for:  Bristol-Myers-Squibb & Gilead Sciences, LLC,  Foster City, CA 94404  Made in Ireland",
      "product_quantity": "39,223 bottles",
      "reason_for_recall": "Presence of Foreign Substance: Red Silicone Rubber Particulates are Present in Drug.",
      "recall_initiation_date": "20140219",
      "center_classification_date": "20140227",
      "termination_date": "20150511",
      "report_date": "20140305",
      "code_info": "Lot #'s: 002390, 002400, Exp 02/17.",
      "more_code_info": ""
    }
  ]
}